Matinas生物制藥（MTNB.US）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

股東類型

公眾及其他75.31%
個人與內幕人士11.95%
私人企業10.16%
機構投資者2.58%

主要股東

主要股東最新
股東
Hezbay Holdings Llc	8.89%	130.65 萬	4.93%	+105.26 萬	13/07/2026
Adam SternFormer Director	8.16%	119.89 萬	5.38%	+102.08 萬	10/07/2026
David Lazar	3.71%	54.50 萬	4.80%	+0	15/08/2025
111 Equity Group LLC	1.25%	18.36 萬	1.62%	+0	13/02/2025
Renaissance Technologies LLC	0.48%	7.10 萬	0.04%	+4.25 萬	30/06/2026
Vanguard Capital Management, LLC	0.39%	5.74 萬	0.52%	-961.00	30/06/2026
BlackRock, Inc.	0.34%	5.03 萬	0.43%	+612.00	30/06/2026
Geode Capital Management, LLC	0.33%	4.91 萬	0.68%	-1.60 萬	30/06/2026
Holos Integrated Wealth, LLC	0.22%	3.25 萬	0.29%	+0	30/06/2026
AKS Family Foundation	0.18%	2.65 萬	0.23%	+0	10/07/2026
Stern Aegis Ventures, Llc Defined Benefit Plan	0.15%	2.14 萬	0.19%	+0	13/02/2025
Susquehanna International Group, LLP	0.11%	1.61 萬	0.11%	+1,765.00	30/06/2026
Citadel Advisors LLC	0.11%	1.55 萬	0.70%	-3.62 萬	30/06/2026
State Street Investment Management	0.10%	1.53 萬	0.13%	+0	30/06/2026
Sargent Investment Group, LLC	0.09%	1.27 萬	0.11%	+0	30/06/2026
Jerome JabbourCo-Founder, Chairman, CEO, President & Interim CFO	0.06%	9,207.00	0.08%	+0	09/05/2025
Pavilion Capital Partners LLC	0.04%	6,000.00	0.05%	+0	10/07/2026
Tower Research Capital Europe Limited	0.02%	2,853.00	0.03%	+0	30/06/2026
Keith KucinskiFormer Chief Financial Officer	0.01%	1,890.00	0.02%	+0	09/05/2025
Robert Eide	0.01%	1,500.00	0.01%	+0	08/04/2025